Section Arrow
Quote
PPCB.OOTC
- Propanc Biopharma, Inc.
  suspend
Quotes are at least 15-min delayed:2025/08/15 06:38 EDT
Pre Market
Last
 --
-- (--)
Bid
--
Ask
--
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 10.4
+2.4 (+30.00%)
Day High 
10.4 
Prev. Close
8 
1-M High
10.81 
Volume 
2.99K 
Bid
--
Ask
--
Day Low
6 
Open
8.72 
1-M Low
3.44 
Market Cap 
92.89M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 8.48 
20-SMA 6.77 
50-SMA 5.17 
52-W High 145.46 
52-W Low 0.0002 
Exchange OOTC 
Valuation Estimation
EPS (Current/Estimated)
-333.31/--
Enterprise Value
92.95M
Balance Sheet
Book Value Per Share
1.56
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
--
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CGTXCognition Therapeutics1.66+0.44+36.07%-- 
Pre Market 1.62 -0.04 -2.41%
ATNF180 Life Sciences Corp7.61-3.09-28.88%0.11PE
Pre Market 6.87 -0.74 -9.72%
ADAPAdaptimmune Therapeutics plc0.0729-0.0053-6.78%-- 
Pre Market 0.073 +0.0001 +0.14%
TNFATNF Pharmaceuticals Inc.0.1023-0.0027-2.57%-- 
Pre Market 0.1055 +0.0032 +3.13%
PSTVPlus Therapeutics0.5422-0.0322-5.61%-- 
Pre Market 0.57 +0.0278 +5.13%
Quotes are at least 15-min delayed：2025/08/15 06:38 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.